Covered recipient · General Payments record
NICOLE S VINCKIER
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2021–2024
$1,552.91
- Reported across 73 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $334.53 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $93.83 | 4 |
| Sage Therapeutics, Inc. | $51.38 | 2 |
| Astellas Pharma US Inc | $46.05 | 3 |
| Organon LLC | $40.93 | 2 |
| Exeltis, USA Inc. | $31.25 | 2 |
| MAYNE PHARMA COMMERCIAL LLC | $30.70 | 1 |
| MILLICENT US INC | $22.55 | 1 |
| Daiichi Sankyo Inc. | $17.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.03 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124992644 | CMS |
| Abbott Laboratories | $14.24 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124992646 | CMS |
| Abbott Laboratories | $21.40 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124992648 | CMS |
| Abbott Laboratories | $35.16 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124992650 | CMS |
| Astellas Pharma US Inc | $13.43 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139499772 | CMS |
| Astellas Pharma US Inc | $13.75 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139462902 | CMS |
| Astellas Pharma US Inc | $18.87 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139558181 | CMS |
| Daiichi Sankyo Inc. | $17.84 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089495254 | CMS |
| Exeltis, USA Inc. | $14.17 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150020965 | CMS |
| Exeltis, USA Inc. | $17.08 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150020967 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $30.70 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154670913 | CMS |
| MILLICENT US INC | $22.55 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150917317 | CMS |
| Organon Llc | $21.12 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136254862 | CMS |
| Organon Llc | $19.81 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136254859 | CMS |
| Sage Therapeutics, Inc. | $28.81 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120405810 | CMS |
| Sage Therapeutics, Inc. | $22.57 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120395733 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.